Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Journal of Virology|March 2, 2013
MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cellsTakayoshi Shirasaki, Masao Honda, Tetsuro Shimakami, et al.
The Journal of Biological Chemistry|August 2, 2021
Epistatic interactions promote persistence of NS3-Q80K in HCV infection by compensating for protein folding instabilityGeorg Dultz, Sanjay K Srikakulam, Michael Konetschnik, et al.
DEN Open|January 24, 2024
Photodynamic therapy with talaporfin sodium for endoscopically unresectable gastric cancer using a novel simultaneous light-emitting methodTomoyuki Hayashi, Kotaro Hayashi, Takeshi Terashima, et al.
International Journal of Molecular Sciences|August 12, 2022
FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome InhibitionRu Li, Hikari Okada, Taro Yamashita, et al.
Scientific Reports|May 30, 2019
Establishment and Characterization of a New Cell Line Permissive for Hepatitis C Virus InfectionHitoshi Omura, Fanwei Liu, Tetsuro Shimakami, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 21, 2020
Comparative analysis of liver functional reserve during lenvatinib and sorafenib for advanced hepatocellular carcinomaTakeshi Terashima, Tatsuya Yamashita, Noboru Takata, et al.
International Journal of Molecular Sciences|May 13, 2023
Plasma Antithrombin III Levels Can Be a Prognostic Factor in Liver Cirrhosis Patients with Portal Vein ThrombosisTsuyoshi Suda, Hajime Takatori, Takehiro Hayashi, et al.
Liver Cancer|July 11, 2020
Direct-Acting Antiviral Agents Reduce the Risk of Malignant Transformation of Hepatobiliary Phase-Hypointense Nodule without Arterial Phase Hyperenhancement to Hepatocellular Carcinoma on Gd-EOB-DPTA-Enhanced Imaging in the Hepatitis C Virus-Infected LiverYoshiaki Shimizu, Kuniaki Arai, Taro Yamashita, et al.
Hepatology (Baltimore, Md.)|December 7, 2013
Hepatic interferon-stimulated genes are differentially regulated in the liver of chronic hepatitis C patients with different interleukin-28B genotypesMasao Honda, Takayoshi Shirasaki, Tetsuro Shimakami, et al.
Journal of Gastroenterology and Hepatology|March 18, 2020
IL-28B variant as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapyTakeshi Terashima, Masao Honda, Tadashi Toyama, et al.
Pageof 12